Pfizer (PFE) Goodwill (2009 - 2026)

Pfizer has disclosed Goodwill across 18 years of filings, most recently posting $71.4 billion for Q1 2026.

• In Q1 2026, Goodwill rose 4.33% year-over-year to $71.4 billion; the TTM figure through Mar 2026 stood at $71.4 billion (up 4.33% YoY), while the FY2025 annual figure was $71.3 billion, up 3.99% from the prior year.
• Goodwill steadied at $71.4 billion in Q1 2026, from $71.3 billion in the prior quarter.
• Over the last five years, Goodwill for PFE reached as high as $71.4 billion in Q1 2026 and fell as low as $49.4 billion in Q4 2022.
• The 5-year median for Goodwill is $68.4 billion (2025), against an average of $61.6 billion.
• Annual changes were most pronounced in 2024 — Goodwill jumped 34.62% — and 2025, when it dropped 1.23%.
• A 5-year view of Goodwill shows it stood at $51.4 billion in 2022, then surged by 31.94% to $67.8 billion in 2023, then climbed by 1.1% to $68.5 billion in 2024, then increased by 3.99% to $71.3 billion in 2025, then advanced by 0.2% to $71.4 billion in 2026.
• According to Business Quant data, Goodwill over the past three periods registered $71.4 billion, $71.3 billion, and $69.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.